Rona Therapeutics is a pioneering nucleic acid therapeutics company to discover, develop and deliver transformative modular RNA medicines to treat patients globally.
Rona Therapeutics is a global leader in nucleic acid innovative drug platform company, specializing in the treatment of metabolic diseases and neurological diseases. Rona Therapeutics is always committed to developing the best and first-in-class siRNA drugs with differentiation and innovation to address unmet needs and improve outcome in cardiovascular diseases, obesity, and MASH. In addition, Rona Therapeutics is unlocking potential of extra-hepatic delivery for neurological disorders and adipose/muscle delivery for various metabolic syndromes.
Company Details
- Employees
- 16
- Founded
- 2021
- Address
- No.795 Kangwei Road, Zhangjiang, Tower 3,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.ronatherapeutics.com
- HQ
- shanghai, 上海市
Rona Therapeutics Questions
Rona Therapeutics's website is https://www.ronatherapeutics.com
Rona Therapeutics's LinkedIn profile is https://cn.linkedin.com/company/ronatherapeutics
Rona Therapeutics has
16 employees.
View email and phone details for 16
employees at Rona Therapeutics.
Rona Therapeutics's industry is
Biotechnology Research
Rona Therapeutics's top competitors are
Lilly Asia Ventures 礼来亚洲基金,
Argo Biopharma,
Atara Biotherapeutics,
Arrowhead Pharmaceuticals,
Fc Capital,
Gro Biosciences,
Structure Therapeutics,
Ronovo Surgical,
Eli Lilly And Company,
Asimov.
Rona Therapeutics's categories are Biotechnology Research
Rona Therapeutics's founding year is 2021
